A massive negative earnings shock, a significantly undervalued company, and a famed investor’s bullish case. Is a price action recovery ahead for Molina Healthcare?
Negative earnings in four out of the past five years, a promising AI future, and high valuations in an ultra-competitive market. Time to sell CrowdStrike after earnings?